Immunohistochemistry for MMR proteins, including MLH1, MSH2, MSH6, and PMS2, was performed to confirm MSI statuses which were determined in CRC tissues by NCI’s five-marker panel (BAT25, BAT26, D2S123, D5S346, and D17S250). This evidence concerns the gene MSH2 and colorectal carcinoma.